Table 1. Pathways affected by LPS Treatment.
| DESeq | |||
|---|---|---|---|
| # | Annotation * | Genes in pathways | P-value |
| 1 | path:mmu04060: Cytokine-cytokine receptor interaction | 146 | 0.0010 |
| 2 | path:mmu00190: Oxidative phosphorylation | 5 | 0.0014 |
| 3 | path:mmu04010: MAPK signaling pathway | 124 | 0.0087 |
| 4 | path:mmu04510: Focal adhesion | 111 | 0.0166 |
| 5 | path:mmu04620: Toll-like receptor signaling pathway | 56 | 0.0215 |
| DEXSeq | |||
| 1 | path:mmu04210: Apoptosis | 31 | 0.0002 |
| 2 | path:mmu04010: MAPK signaling pathway | 28 | 0.0094 |
| 3 | path:mmu04060: Cytokine-cytokine receptor interaction | 22 | 0.0324 |
| 4 | path:mmu05050: Dentatorubropallidoluysian atrophy (DRPLA) | 5 | 0.0362 |
| 5 | path:mmu04620: Toll-like receptor signaling pathway | 12 | 0.0384 |
*Innate immune signaling pathways underlined.